After 18 Years, FDA Approves Malaria Prevention Drug

A Washington-based company, Sixty Degrees Pharmaceuticals, has begun the distribution of a new anti-malarial drug, Arakoda (tafenoquine) into the US healthcare marketplace. This is a drug that has been approved for the prevention of malaria in adults. This is the first anti-malaria product that the US Food and Drug Administration (FDA) has approved in over 18 years.